Hepion Pharmaceuticals logo
Hepion Pharmaceuticals HEPA

Quarterly report 2025-Q3
added 11-12-2025

report update icon

Hepion Pharmaceuticals Long Term Debt Current 2011-2026 | HEPA

Annual Long Term Debt Current Hepion Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 116 K 53.6 K 267 K 280 K 267 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
280 K 53.6 K 197 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 21.66 1.14 % $ 1.01 B usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.9 -0.2 % $ 6.62 M chinaChina
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.33 1.66 % $ 3.7 B usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 1.94 1.31 % $ 403 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
22 K $ 2.38 2.33 % $ 152 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
3.04 M $ 1.18 -0.84 % $ 197 M usaUSA
ImmuCell Corporation ImmuCell Corporation
ICCC
85.5 K $ 8.26 -1.07 % $ 74.6 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
257 K $ 1.61 8.78 % $ 152 M germanyGermany
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Jaguar Health Jaguar Health
JAGX
192 K $ 0.29 -25.25 % $ 676 K usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
1.62 M $ 19.09 -2.75 % $ 1.03 B britainBritain
BioNTech SE BioNTech SE
BNTX
45 M $ 102.36 -2.94 % $ 27.2 B germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.11 0.61 % $ 439 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 23.18 -0.34 % $ 2.95 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.43 -0.7 % $ 381 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
1.27 M $ 240.72 4.09 % $ 4.4 B usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Eli Lilly and Company Eli Lilly and Company
LLY
222 M $ 874.81 -1.06 % $ 785 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.9 -0.34 % $ 4.77 M israelIsrael